EKB Journal Management System
1.

Evaluation of Circulating MicroRNA-130b as a novel non-invasive biomarker for Hepatocellular Carcinoma

Articles in Press, Accepted Manuscript , Available Online from 01 January 2026
Neveen A. Hassan; Tahra M. Kamel; Mohamed M. Abd El-Gaber; Zainab G. Mahran
2.

Added Value of PET/CT in Assessment of Hepatocellular Malignancy Post Radiofrequency Ablation

Volume 101, Issue 1, October 2025, Pages 4595-4601
3.

Breaking the AFP Barrier: CD166 as a Next-Generation Biomarker for Hepatocellular Carcinoma Detection

Volume 100, Issue 1, July 2025, Pages 3768-3773
4.

Association of AURKA Polymorphisms with the Development and Progression of Hepatocellular Carcinoma in Egyptian Patients

Volume 11, Issue 1, June 2025, Pages 13-21
HAZEM ABDELSALAM; Moustafa Sakr; samir elmasry; Mohamed Abied; gamal badra
5.

Evaluation of Serum and Ascetic Fluid Calprotectin for Detection of Hepatocellular Carcinoma in Cirrhotic Patients

Volume 7, Issue 3, March 2025, Pages 5480-5484
Ahmed Elsayed Hasan; Magdy Abdelkareem El dahshan; Saad Eldeen Mohammed ELSheref; Tarek Mustafa Emran; Taiseer Ahmed Shawky
6.

Alpha-L-Fucosidase Versus Alpha-Fetoprotein: A Comparative Study for Diagnosing Hepatocellular Carcinoma in Post-Viral Cirrhotic Patients

Volume 76, Issue 1, March 2025, Pages 185-196
Sherif Ahmed Megahed; Sameh Moamed Faheem Ghaly; Moamen Abd-elfattah Shabaan; Marwa Ahmed Mohamed Mohamed Sakr
7.

Serum Glypican-3 versus Alpha-fetoprotein in Patients with Hepatocellular Carcinoma on Top of HCV Related Liver Cirrhosis

Volume 31, Issue 1, January 2025, Pages 17-27
Mahmoud Abdo Ashour; Asmaa Mohamed Hosny Osh; Saada Elsayed Salama; Samir A. Afifi
8.

Evaluation of The Role of Serum Epidermal Growth Factor Like Domain 7 as A New Non-Invasive Diagnostic Marker for Hepatocellular Carcinoma in Egyptian Cirrhotic Patients

Volume 97, Issue 1, October 2024, Pages 3660-3666
9.

Evaluation The Association of Aldo-Keto Reductase Family 1 Member B10 With Hepatocellular Carcinoma

Volume 41, Issue 5, September 2024, Pages 220-231
Badawy Abdulkhalik Abdulaziz; Fatma Mohamed Abd-Elsalam; Gamel Elsayed Elsheshtawy Elmorsy; Reham Helmy Amin; Waleed Abdellatif Abdelaleem; Ahmed Saafan
10.

Circulating DiGeorge Syndrome Critical Region (5) as a Tumor Suppressor Gene in Hepatocellular Carcinoma

Volume 2, Issue 2, July 2024, Pages 13-20
Asmaa El-banna; Ghada Hamoda; Sally Elhefnawy; Alshimaa M. Alhanafy
11.

Pattern of Serum Osteopontin Level in Patients with Cirrhotic Liver versus Patients with Hepatocellular Carcinoma

Volume 26, Issue 5, May 2023, Pages 0-0
Mohamed Y. El-shafaey; Seham A. Omar; Ayman S. Amer; Mohamed M. El-shabrawy
12.

Evaluation of AFP for diagnosis of HCC in Egyptian patients

Volume 5, Issue 1, March 2023, Pages 43-48
Ahmed Abdelhalim Yameny; Sabah Farouk Alabd; Magda Ahmed M. Mansor
13.

Influence of Cytokeratin-19 Level on Pattern of Hepatocellular Carcinoma in Patients with Liver Cirrhosis

Volume 89, Issue 1, October 2022, Pages 5444-5451
Ahmed Adel Saad; Salah El Din Abdel hakim El Gamal; Shimaa R. Hendawy; Ahmed Saleh
14.

Evaluation of the Potential role of MicroRNA 126 in Hepatitis C infection patients treatment Outcomes

Volume 42, Issue 2, September 2022, Pages 19-24
Dalia Mohamed Shaker Elkholy; Mohamed Mahfouz
15.

Serum Golgi protein 73 and glypican-3: early diagnostic biomarkers for hepatocellular carcinoma

Volume 27, Issue 3, August 2022
Doaa F. Gad; Islam Eid Mohamed; Essam Elmahdi; Abdelnaser A. Badawy; Gamal Othman; Mohamed G. Dawoud; Mohammed Diasty; Maysaa E. Zaki; Mohamed M. Abd El-Mawgod
16.

Serum Level of Cluster of Differentiation 166 in Diagnosis of Hepatocellular Carcinoma

Volume 39, Issue 2, July and August 2022, Pages 397-408
Marwa Shabaan Mohamed; Amany Lashin; Shuzan All Mohamed; Hany Ragheb El-Kholy
17.

Changes in Alpha-fetoprotein, Phosphorus, Calcium, and Metabolic Hormones in Goats had Singleton, Twin, and Triplet Pregnancy

Volume 53, Issue 1, April 2022, Pages 15-23
Omnia El-sayed; Mohamed kandil; Karima Ghoneimy M.; Mahmoud Abou El-Roos; Sally Rashad Elsaid Ibrahim
18.

Promoter methylation of certain tumor regulatory genes and hepatocellular carcinoma

Volume 6, Issue 1, April 2022, Pages 69-83
Mai Mohamed Abo ELazm
19.

Effect of Doxorubicin and Cisplatin on Alpha-fetoprotein levels in Hepatocellular Carcinoma Cell lines

Volume 3, Issue 1, January 2022, Pages 35-44
Nabil Mohie Abdel-Hamid; Mohammed Samy EL-Gharieb; Fardous Fawzy El- Senduny; Nadia Abdel- Aziz Alnakib
20.

CHROMOGRANIN-A AS A NEW SERUM MARKER FOR DIAGNOSIS OF HEPATOCELLULAR CARCINOMA

Volume 51, Issue 1, January 2022, Pages 709-718
Ahmed Abd El-Twab Abd El-Aziz; Ibrahim M. El-hosiny; Heba Abdella; Ayman Abd El-Aziz
21.

Is it time now to stop searching for other tumor markers for HCC apart from alpha-fetoprotein?

Volume 4, Issue 1, July 2021, Pages 26-28
Ahmed Elsayed Mohamed Esmaiel
22.

Serum biomarkers of hepatocellular carcinoma in patients with liver cirrhosis: a narrative review

Volume 4, Issue 1, July 2021, Pages 33-43
Salem Youssef Mohamed; Ahmed Elsayed Esmaiel; Marwa Abo Shabana; Nevin Fouad Ibrahim
23.

Serum Thioredoxin as a Diagnostic Marker for Hepatocellular Carcinoma in Cirrhotic Hepatitis C Patients

Volume 5.2, Issue 2, March 2021, Pages 9-15
Tarek Sheta; Mahmoud Selim; Mohammed Sabry; Ahmed Saed
24.

Impact of CA19-9 in Diagnosis of Combined Hepatocellular Carcinoma and Cholangiocarcinoma

Volume 5, Issue 8 part (1) - (2), December 2020, Pages 195-199
Y.S. Younes; B.A. Abdul-Aziz; W.A. El-Agawy; W.M.M. Ahmed
25.

Serum Long Intergenic Non-Coding Ribonucleic Acid LINC00152 as a Potential Predictor of Hepatocellular Carcinoma in Egyptian Patients

Volume 10, Issue 3, September 2020, Pages 264-270
Ehsan Abdelrahman; Ahmed Abd El-Aal; Mona Sobhy; Ayman Shamsya; Yasmin Zanet; Essam El-Din S Bedewy
First Page Previous Page 1 2 Next Page Last Page